Mazor Robotics Ltd. (TASE: MZOR) (NASDAQ GM: MZOR), a developer of
innovative guidance systems and complementary products, announced today
that it has sold a second Renaissance system to Westside Surgical
Hospital located in Houston, Texas. This represents the third
Renaissance system in the Houston area and eighth Renaissance system in
the state of Texas. Westside Surgical Hospital is part of the K+S
Consulting Group, an owner and operator of hospitals and outpatient
surgical centers, including Humble Surgical Hospital, another
Renaissance system site.
The Renaissance system will be installed at Westside Surgical Hospital,
where renowned orthopedic surgeon, Dr. Richard Francis, regularly
operates. It will be the second Renaissance system installed by Westside
Surgical and will be used for clinical and training purposes.
"The success of the Renaissance system, which is supported by the number
of procedures performed and the business and clinical benefits, is
driving increased interest from surgeons and hospital administrators,"
commented Ori Hadomi, Mazor's Chief Executive Officer. "Furthermore, in
choosing to add a second system for clinical and training purposes,
Westside Surgical sees the future value of Renaissance as it seeks to
enhance and broaden surgeon participation."
Westside Surgical Hospital is a multi-specialty surgical hospital
created to serve all people through exemplary healthcare, education and
community service. With 12 overnight beds and six operating rooms,
Westside Surgical Hospital is equipped to perform a wide range f
inpatient and outpatient procedures and specializes in breast,
orthopedic and spine surgery, among a wide range of surgical and
diagnostic offerings. It performs 4,500 surgical procedures annually,
and its mission is to provide the highest quality services in a safe,
welcoming and comfortable environment.
Mazor Robotics is dedicated to the development and marketing of
innovative surgical guidance system and complementary products that
provide a safer surgical environment for patients, surgeons, and
operating room staff. Mazor Robotics' flagship product, Renaissance™, is
a state-of-the-art surgical Guidance system that enables surgeons to
conduct spine surgeries in an accurate and secure manner. Mazor Robotics
systems have been successfully used in the placement of over 35,000
implants worldwide. Numerous peer-reviewed publications and
presentations at leading scientific conferences have validated the
accuracy, usability, and clinical advantages of Mazor Robotics
technology. For more information, the content of which is not part of
this press release, please visit www.mazorrobotics.com.
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Any
statements in this release about future expectations, plans or prospects
for the Company, including without limitation, statements regarding
increased interest from surgeons and hospital administrators, the
benefits and future value of Renaissance, and other statements
containing the words "believes," "anticipates," "plans," "expects,"
"will" and similar expressions are forward-looking statements. These
statements are only predictions based on Mazor's current expectations
and projections about future events. There are important factors that
could cause Mazor's actual results, level of activity, performance or
achievements to differ materially from the results, level of activity,
performance or achievements expressed or implied by the forward-looking
statements. Those factors include, but are not limited to, the impact of
general economic conditions, competitive products, product demand and
market acceptance risks, reliance on key strategic alliances,
fluctuations in operating results, and other factors indicated in
Mazor's filings with the Securities and Exchange Commission (SEC)
including those discussed under the heading "Risk Factors" in Mazor's
registration statement on Form F-1 and in subsequent filings with the
SEC. For more details, refer to Mazor's SEC filings and the amendments
thereto. Mazor undertakes no obligation to update forward-looking
statements to reflect subsequent occurring events or circumstances, or
to changes in our expectations, except as may be required by law.
[ Back To NFVZone's Homepage ]